Berna H. Beverloo

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Inotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial.

Inotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial.

Journal: The Lancet. Haematology

Published: January 27, 2026

Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin.

Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin.

Journal: Haematologica

Published: October 16, 2025

MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Journal: Blood advances

Published: September 11, 2025

Daratumumab-based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study.

Daratumumab-based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study.

Journal: HemaSphere

Published: July 18, 2025

MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.

MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.

Journal: Blood

Published: February 21, 2025

Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma.

Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma.

Journal: Investigative ophthalmology & visual science

Published: February 06, 2024

Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 30, 2023

Association of unbalanced translocation der(1;7) with germline GATA2 mutations.

Association of unbalanced translocation der(1;7) with germline GATA2 mutations.

Journal: Blood

Published: June 04, 2021

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial.

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial.

Journal: Blood advances

Published: November 18, 2020

Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study.

Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study.

Journal: British journal of haematology

Published: February 26, 2018

Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma.

Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma.

Journal: Ophthalmology

Published: October 18, 2016

Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.

Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.

Journal: Oncotarget

Published: July 08, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026